Overview
CD3 operates as an investment fund and drug discovery center focusing on discovering new drugs based on innovative science from partner institutions. The organization bridges the gap between biomedical research from academic institutes and biotechs with the pharmaceutical industry, offering state-of-the-art drug discovery expertise and capabilities while investing in drug discovery spin-offs and biotechs.
In the news
Related profiles
Something wrong or missing? Send an update. Fixed within 24 hours.